SCHEMBL5515053

SCHEMBL5515053

Cc1ccc(NC(=O)c2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 18/20 0.84
BCR P11274 15/20 0.84
KIT P10721 11/20 0.84
PDGFRA P16234 5/20 0.84
ABL2 P42684 4/20 0.84
PDGFRB P09619 3/20 0.84
EGFR P00533 2/20 0.84
ERBB2 P04626 2/20 0.84
LCK P06239 2/20 0.84
FYN P06241 2/20 0.84
CSF1R P07333 2/20 0.84
LYN P07948 2/20 0.84
FGR P09769 2/20 0.84
SRC P12931 2/20 0.84
BRAF P15056 2/20 0.84
NQO2 P16083 2/20 0.84
EPHA8 P29322 2/20 0.84
FRK P42685 2/20 0.84
BLK P51451 2/20 0.84
DDR1 Q08345 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Masitinib SCHEMBL1096348 0.93 ABL1 (0.94) ABL1BCRKITPDGFRAABL2
Masitinib SCHEMBL2297143 0.93 ABL1 (0.94) ABL1BCRKITPDGFRAABL2
Masitinib SCHEMBL30024483 0.93 ABL1 (0.94) ABL1BCRKITPDGFRAABL2
SCHEMBL16085058 0.91 ABL1 (0.89) ABL1BCRKITPDGFRAABL2
Masitinib SCHEMBL717239 0.91 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
Masitinib SCHEMBL29353195 0.91 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
Masitinib SCHEMBL29355443 0.91 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
SCHEMBL717173 0.91 ABL1 (0.88) ABL1BCRKITPDGFRAABL2
SCHEMBL6407506 0.91 ABL1 (0.70) ABL1BCRKITPDGFRAABL2
SCHEMBL26359118 0.91 ABL1 (0.87) ABL1BCRKITPDGFRAABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126153-A New coronavirus inhibitor, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-11-28 CN disclosed
EP-1758654-A1 USE OF C-KIT INHIBITORS FOR TREATING PLASMODIUM RELATED DISEASES AB Science (FR) 2007-03-07 EP disclosed
WO-2005102455-A1 USE OF C-KIT INHIBITORS FOR TREATING PLASMODIUM RELATED DISEASES AB SCIENCE (FR) 2005-11-03 WO disclosed